Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

NCT05214573 · clinicaltrials.gov ↗

COMPLETED

Status

386301

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Cardiac Disease

Interventions

DRUG: Glucagon like peptide 1 receptor agonist
DRUG: Sodium-glucose cotransporter 2 inhibitor
DRUG: Dipeptidyl Peptidase 4 Inhibitor
DRUG: Sulfonylurea

Sponsor

Mayo Clinic

Collaborators

[object Object]